tiprankstipranks
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
US Market

IGM Biosciences (IGMS) Income Statement

Compare
334 Followers

IGM Biosciences Income Statement

Last quarter (Q3 2024), IGM Biosciences's total revenue was $516.00K, an increase of 1.38% from the same quarter last year. In Q3, IGM Biosciences's net income was $-61.43M. See IGM Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.13M$ 1.07M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.15M$ -9.53M$ -7.72M$ -3.58M$ -2.33M
Operating Expenses
$ 265.59M$ 229.03M$ 165.32M$ 83.28M$ 44.50M
Depreciation and Amortization
$ 8.28M$ 10.60M$ 7.72M$ 3.58M$ 2.33M
EBITDA
$ -253.36M$ -221.88M$ -157.44M$ -77.78M$ -40.80M
Operating Income
$ -263.46M$ -227.96M$ -165.32M$ -83.28M$ -44.50M
Other Income/Expenses
$ 17.72M$ 6.85M$ 159.00K$ 1.93M$ 1.36M
Pretax Income
$ -245.74M$ -221.10M$ -165.16M$ -81.36M$ -43.13M
Net Income
$ -246.42M$ -214.25M$ -160.68M$ -80.33M$ -42.54M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.71$ -5.16$ -4.80$ -2.61$ -4.73
Diluted EPS
$ -4.71$ -5.16$ -4.80$ -2.61$ -4.73
Weighted Average Shares Outstanding
52.31M 41.54M 33.48M 30.75M 9.00M
Weighted Average Shares Outstanding (Diluted)
52.31M 41.54M 33.48M 30.75M 9.00M
Currency in USD

IGM Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis